Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02649075 · ClinicalTrials.gov registry record · NA
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A NA study, sponsored by Entera Health.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02649075 is a NA study that was terminated before completion, run by Entera Health. The registered enrollment target is 7 participants.
The verdict
NCT02649075, a NA study, was terminated before completion, sponsored by Entera Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the nutritional therapy with SBI (a medical food) as compared to placebo in the clinical dietary management of mild to moderate Crohn's disease.
Interventions
- OTHER Placebo
- OTHER Serum-derived Bovine Immunoglobulin / Protein Isolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02649075
The ClinicalTrials.gov registry entry for NCT02649075 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Entera Health, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02649075 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02649075 about?
NCT02649075 is a clinical study titled "To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease". The objective of this study is to evaluate the nutritional therapy with SBI (a medical food) as compared to placebo in the clinical dietary management of mild to moderate Crohn's disease.
What is the current status of trial NCT02649075?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2016-02. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02649075?
The interventions under investigation include: Placebo (OTHER), Serum-derived Bovine Immunoglobulin / Protein Isolate (OTHER).
Who is sponsoring clinical trial NCT02649075?
This trial is sponsored by Entera Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.